Joel Chua

Associate Professor

University of Maryland School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Joel Chua is an Associate Professor at the University of Maryland School of Medicine in the United States. His research areas include immunology, hepatitis virus therapies, and dengue virus infection, as highlighted in his recent publications. Dr. Chua has contributed significantly to understanding cross-reactivity in flavivirus protection and the safety and efficacy of HIV and hepatitis treatments.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Bryan Mayer

Fred Hutchinson Cancer Research Center

UNITED STATES

View details

Juan Carlos Zapata

University of Maryland School of Medicine

UNITED STATES

View details

Amy Nelson

Assistant Professor

University of Augsburg

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joel Chua

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity

Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults with HIV/HBV Coinfection: An Open-Label, Single-Arm, Safety and Efficacy Switch Study

Evaluation of Four Humanized NOD-Derived Mouse Models for Dengue Virus-2 Infection

RNA Interference Therapeutics for Chronic Hepatitis B: Progress, Challenges, and Future Prospects

A Comparison of Lymphoid and Myeloid Cells Derived from Human Hematopoietic Stem Cells Xenografted into NOD-Derived Mouse Strains

A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection

Immune-Mediated Pathogenesis in Dengue Virus Infection

Current Trends and Limitations in Dengue Antiviral Research

Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial

Short‐duration treatment with the novel non‐nucleoside inhibitor CDI‐31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open‐label study

Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression

Campylobacter fetus aortitis in a patient with HIV

Evolution of Nipah Virus Infection: Past, Present, and Future Considerations

Dengue Infections in Colombia: Epidemiological Trends of a Hyperendemic Country

Collaborators (3)

Bryan Mayer

Juan Carlos Zapata

Amy Nelson

Make your next move.